• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过移植微囊化原代或永生化异种肝细胞治疗暴发性肝衰竭。

Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.

作者信息

Mai Gang, Nguyen Tuan Huy, Morel Philippe, Mei Jie, Andres Axel, Bosco Domenico, Baertschiger Reto, Toso Christian, Berney Thierry, Majno Pietro, Mentha Gilles, Trono Didier, Buhler Leo H

机构信息

Surgical Research Unit, Department of Surgery, University Hospital Geneva, Switzerland.

出版信息

Xenotransplantation. 2005 Nov;12(6):457-64. doi: 10.1111/j.1399-3089.2005.00248.x.

DOI:10.1111/j.1399-3089.2005.00248.x
PMID:16202069
Abstract

BACKGROUND

The aim of this study was to evaluate in vitro and in vivo functions of isolated hepatocytes after immortalization, cryopreservation, encapsulation and xenotransplantation into mice with fulminant liver failure (FLF).

METHODS

Rat and human hepatocytes were isolated from normal liver tissue by collagenase digestion. Human hepatocytes were immortalized using lentiviral vectors coding for SV 40 large T antigen, Bmi-1 and telomerase. Rat and immortalized human hepatocytes (IHH) were encapsulated in 400 micron alginate-PLL-alginate membranes and cryopreserved using a computerized device. In vitro, encapsulated hepatocytes (cryopreserved or freshly isolated) were cultured in albumin-free medium and albumin production was measured by enzyme-linked immunosorbent assay (ELISA). In vivo, a model of FLF was established in C57/BL6 mice by acetaminophen administration (700 mg/kg i.p.) followed 15 h later by a 30% hepatectomy. Microencapsulated (cryopreserved or freshly isolated) hepatocytes were transplanted intraperitoneally to mice with FLF and the following experimental groups were performed: group 1 (n = 10) Tx of empty capsules; group 2 (n = 12) Tx of free primary rat hepatocytes; group 3 (n = 12) Tx of cryopreserved encapsulated rat hepatocytes; group 4 (n = 10) Tx of fresh encapsulated rat hepatocytes; group 5 (n = 9) Tx of cryopreserved encapsulated IHH; group 6 (n = 10) Tx of fresh encapsulated IHH. Animals were killed at regular intervals and histopathology of microcapsules and liver tissue was obtained.

RESULTS

In vitro, cryopreserved or fresh encapsulated rodent hepatocytes showed a progressively decreasing albumin secretion over 1 week in culture. In contrast, cryopreserved or fresh encapsulated IHH showed minimal, but stable albumin secretion. In vivo, FLF was achieved by combination of acetaminophen with 30% hepatectomy, resulting in a reproducible survival of 23% +/- 5%. In groups 1 and 2, survival rates were not improved significantly compared with untreated mice. In groups 3 and 4, Tx of cryopreserved or fresh encapsulated rat hepatocytes significantly increased survival rate to 66% and 80%, respectively (P < 0.01). In groups 5 and 6, Tx of cryopreserved or fresh encapsulated IHH improved survival to 50% and 55%, respectively (P < 0.05). Histopathology revealed that encapsulated hepatocytes were viable up to 2 weeks post-Tx.

CONCLUSIONS

Primary rodent hepatocytes maintained synthetic functions after encapsulation and cryopreservation short-term. IHH showed minimal albumin secretion in the absence of encapsulation and cryopreservation, suggesting that hepatocytes loose specific functions after immortalization. After induction of FLF in mice, intraperitoneal Tx of encapsulated (primary or immortalized, fresh or cryopreserved) xenogeneic hepatocytes significantly improved survival. These results indicate that naïve and genetically modified hepatocytes can successfully be encapsulated, stored using cryopreservation, and be transplanted into xenogeneic recipients with liver failure and sustain liver metabolic functions.

摘要

背景

本研究旨在评估永生化、冷冻保存、封装及异种移植到暴发性肝衰竭(FLF)小鼠体内后分离的肝细胞的体外和体内功能。

方法

通过胶原酶消化从正常肝组织中分离大鼠和人肝细胞。使用编码SV 40大T抗原、Bmi-1和端粒酶的慢病毒载体使人肝细胞永生化。将大鼠和永生化人肝细胞(IHH)封装在400微米的海藻酸盐-聚赖氨酸-海藻酸盐膜中,并使用计算机控制的设备进行冷冻保存。体外,将封装的肝细胞(冷冻保存的或新鲜分离的)在无白蛋白培养基中培养,并通过酶联免疫吸附测定(ELISA)测量白蛋白产生。体内,通过腹腔注射对乙酰氨基酚(700 mg/kg)建立C57/BL6小鼠FLF模型,15小时后进行30%肝切除术。将微封装的(冷冻保存的或新鲜分离的)肝细胞腹腔内移植到FLF小鼠体内,并进行以下实验组:第1组(n = 10)为空胶囊移植组;第2组(n = 12)为游离原代大鼠肝细胞移植组;第3组(n = 12)为冷冻保存的封装大鼠肝细胞移植组;第4组(n = 10)为新鲜封装的大鼠肝细胞移植组;第5组(n = 9)为冷冻保存的封装IHH移植组;第6组(n = 10)为新鲜封装的IHH移植组。定期处死动物,获取微胶囊和肝组织的组织病理学结果。

结果

体外,冷冻保存的或新鲜封装的啮齿动物肝细胞在培养1周内白蛋白分泌逐渐减少。相比之下,冷冻保存的或新鲜封装的IHH白蛋白分泌极少,但稳定。体内,对乙酰氨基酚与30%肝切除术联合导致FLF,可重复性生存率为23%±5%。在第1组和第2组中,与未治疗的小鼠相比,生存率没有显著提高。在第3组和第4组中,冷冻保存的或新鲜封装的大鼠肝细胞移植分别使生存率显著提高到66%和80%(P < 0.01)。在第5组和第6组中,冷冻保存的或新鲜封装的IHH移植分别使生存率提高到50%和55%(P < 0.05)。组织病理学显示,封装的肝细胞在移植后2周内仍存活。

结论

原代啮齿动物肝细胞在封装和短期冷冻保存后仍保持合成功能。IHH在未进行封装和冷冻保存时白蛋白分泌极少,表明肝细胞永生化后失去了特定功能。在小鼠诱导FLF后,腹腔内移植封装的(原代或永生化、新鲜或冷冻保存的)异种肝细胞显著提高了生存率。这些结果表明,未处理的和基因修饰的肝细胞能够成功地进行封装、冷冻保存,并移植到异种肝衰竭受体中,维持肝脏代谢功能。

相似文献

1
Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.通过移植微囊化原代或永生化异种肝细胞治疗暴发性肝衰竭。
Xenotransplantation. 2005 Nov;12(6):457-64. doi: 10.1111/j.1399-3089.2005.00248.x.
2
Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.通过移植微囊化原代或永生化异种肝细胞治疗暴发性肝衰竭。
Transplant Proc. 2005 Jan-Feb;37(1):527-9. doi: 10.1016/j.transproceed.2005.01.017.
3
Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice.通过移植微囊化冻存猪肝细胞提高小鼠暴发性肝衰竭的存活率。
Cell Transplant. 2009;18(1):101-10. doi: 10.3727/096368909788237168.
4
Transplanted cryopreserved encapsulated porcine hepatocytes are as effective as fresh hepatocytes in preventing death from acute liver failure in rats.移植冷冻保存的封装猪肝细胞在预防大鼠急性肝衰竭死亡方面与新鲜肝细胞同样有效。
Transplantation. 2000 Jul 15;70(1):58-64.
5
Peritoneal implantation of cryopreserved encapsulated porcine hepatocytes in rats without immunosuppression: viability and function.未经免疫抑制的大鼠腹腔内植入冷冻保存的封装猪肝细胞:生存能力与功能
Transplant Proc. 2008 Jul-Aug;40(6):2049-52. doi: 10.1016/j.transproceed.2008.05.038.
6
Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration.急性肝衰竭时包裹肝细胞的移植可提高存活率而不刺激内源性肝再生。
Cell Transplant. 2011;20(11-12):1791-803. doi: 10.3727/096368911X564976. Epub 2011 Mar 7.
7
Coencapsulation of hepatocytes with bone marrow mesenchymal stem cells improves hepatocyte-specific functions.肝细胞与骨髓间充质干细胞共包封可改善肝细胞的特异性功能。
Transplantation. 2009 Nov 27;88(10):1178-85. doi: 10.1097/TP.0b013e3181bc288b.
8
In vitro analysis of cryopreserved alginate-poly-L-lysine-alginate-microencapsulated human hepatocytes.体外分析冷冻保存的藻酸盐-聚-L-赖氨酸-藻酸盐微囊化人肝细胞。
Liver Int. 2010 Apr;30(4):611-22. doi: 10.1111/j.1478-3231.2009.02197.x. Epub 2010 Jan 11.
9
Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90% hepatectomized mice.永生化人胎儿肝细胞移植可预防90%肝切除小鼠的急性肝衰竭。
Transplant Proc. 2010 Jun;42(5):1907-14. doi: 10.1016/j.transproceed.2010.01.061.
10
Microencapsulated multicellular spheroid of rat hepatocytes transplanted intraperitoneally after 90% hepatectomy.90%肝切除术后经腹腔移植的大鼠肝细胞微囊化多细胞球体。
Hepatogastroenterology. 2002 Nov-Dec;49(48):1514-6.

引用本文的文献

1
Contributions of Europeans to Xenotransplantation Research: 2. Pig Islet and Cell Xenotransplantation.欧洲人对异种移植研究的贡献:2. 猪胰岛和细胞异种移植。
Transpl Int. 2025 Apr 17;38:14143. doi: 10.3389/ti.2025.14143. eCollection 2025.
2
Freezing biological organisms for biomedical applications.为生物医学应用冷冻生物有机体。
Smart Med. 2022 Dec 27;1(1):e20220034. doi: 10.1002/SMMD.20220034. eCollection 2022 Dec.
3
A comprehensive review of advances in hepatocyte microencapsulation: selecting materials and preserving cell viability.
肝细胞微囊化技术进展的综合评述:材料选择与细胞活力保存。
Front Immunol. 2024 Apr 17;15:1385022. doi: 10.3389/fimmu.2024.1385022. eCollection 2024.
4
Engineering liver microtissues for disease modeling and regenerative medicine.用于疾病建模和再生医学的工程化肝脏微组织
Adv Funct Mater. 2020 Oct 28;30(44). doi: 10.1002/adfm.201909553. Epub 2020 Feb 19.
5
Cryopreservation of Hepatocyte Microbeads for Clinical Transplantation.肝细胞微球的低温保存用于临床移植。
Cell Transplant. 2017 Aug;26(8):1341-1354. doi: 10.1177/0963689717720050.
6
New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy.急性肝衰竭的新策略:聚焦于异种移植治疗
Cell Med. 2010 Jul 1;1(1):47-54. doi: 10.3727/215517910X516646. eCollection 2010.
7
Experimental hepatocyte xenotransplantation--a comprehensive review of the literature.实验性肝细胞异种移植——文献综述
Xenotransplantation. 2015 Jul-Aug;22(4):239-48. doi: 10.1111/xen.12170. Epub 2015 May 7.
8
Alginate microencapsulated hepatocytes optimised for transplantation in acute liver failure.为急性肝衰竭移植优化的海藻酸盐微囊化肝细胞。
PLoS One. 2014 Dec 1;9(12):e113609. doi: 10.1371/journal.pone.0113609. eCollection 2014.
9
DNA methylation profiling of the fibrinogen gene landscape in human cells and during mouse and zebrafish development.在人类细胞以及在小鼠和斑马鱼发育过程中,纤维蛋白原基因景观的 DNA 甲基化分析。
PLoS One. 2013 Aug 21;8(8):e73089. doi: 10.1371/journal.pone.0073089. eCollection 2013.
10
Use of Magnetocapsules for In Vivo Visualization and Enhanced Survival of Xenogeneic HepG2 Cell Transplants.磁胶囊用于体内可视化及提高异种移植的 HepG2 细胞存活率
Cell Med. 2012 Feb 1;4(2):77-84. doi: 10.3727/215517912X653337.